No insider-trading filing for this company in the last two years.
| Filed | Person | Category | Type | Mode | Quantity | Value | Holding after |
|---|---|---|---|---|---|---|---|
| 7 Apr 2021 | Ipca Laboratories Limitedip | Promoter | Buy | Conversion of security | 0 | ₹0 | 49.65% from 44.67% |
| 14 Sep 2020 | Ipca Laboratories Limited | Promoter | Buy | Conversion of security | 0 | ₹0 | 44.67% from 39.69% |
| 6 Feb 2020 | Ipca Laboratories Limited | Promoter | Buy | Preferential Offer | 0 | ₹0 | 39.69% from 34.73% |
| 2 Apr 2019 | Ajay Ravi | Promoter group | Buy | Public Right | 0 | ₹0 | 0.67% from 0.67% |
| 1 Apr 2019 | Ipca Laboratories Limited | Promoter | Buy | Public Right | 0 | ₹0 | 34.73% from 29.83% |
| 1 Apr 2019 | Avinash Ravi | Promoter | Buy | Public Right | 0 | ₹0 | 12.87% from 12.87% |
| 1 Apr 2019 | Hemalata Ravi | Promoter | Buy | Public Right | 0 | ₹0 | 16.18% from 16.18% |
| 4 Oct 2017 | Avinash Ravi | Immediate relative | Buy | Gift | 0 | ₹0 | 12.87% from 11.56% |
| 4 Oct 2017 | R T Ravi | Immediate relative | Sell | Gift | 0 | ₹0 | 0.14% from 1.44% |
| 25 Jul 2016 | Hemalata Ravi | Promoter | Buy | Preferential Offer | 0 | ₹0 | 16.18% from 11.82% |
Showing the most recent disclosures only. Sign in to see more, or upgrade your plan to see the full history. Sign in
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
